Could a pill boost brain function in Huntington's? new trial tests SAGE-718
NCT ID NCT05107128
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested an experimental drug called SAGE-718 to see if it could improve cognitive function (like attention and processing speed) in people with Huntington's disease. 189 participants took either the drug or a placebo daily for a period of time. The main goal was to measure changes in a symbol-digit matching test. The trial has completed, and results will show whether SAGE-718 offers any benefit for thinking skills in Huntington's.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SAGE-718 (oral capsules)
What this could lead to
If it works, this could point toward a treatment to help with thinking and memory problems in Huntington's disease.
What could go wrong
This is a Phase 2 trial, so results are still early. The drug may not improve cognition significantly, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Little Rock, Arkansas, 72205, United States
-
Sage Investigational Site
La Jolla, California, 92037, United States
-
Sage Investigational Site
Los Angeles, California, 90095, United States
-
Sage Investigational Site
Sacramento, California, 95817, United States
-
Sage Investigational Site
Englewood, Colorado, 80113, United States
-
Sage Investigational Site
Washington D.C., District of Columbia, 20007, United States
-
Sage Investigational Site
Boca Raton, Florida, 33431, United States
-
Sage Investigational Site
Boca Raton, Florida, 33486, United States
-
Sage Investigational Site
Tampa, Florida, 33612, United States
-
Sage Investigational Site
Honolulu, Hawaii, 96817, United States
-
Sage Investigational Site
Chicago, Illinois, 60611, United States
-
Sage Investigational Site
Chicago, Illinois, 60612, United States
-
Sage Investigational Site
Indianapolis, Indiana, 46202, United States
-
Sage Investigational Site
Iowa City, Iowa, 52242, United States
-
Sage Investigational Site
Kansas City, Kansas, 66160, United States
-
Sage Investigational Site
Baltimore, Maryland, 21287, United States
-
Sage Investigational Site
Boston, Massachusetts, 02129, United States
-
Sage Investigational Site
Boston, Massachusetts, 02215, United States
-
Sage Investigational Site
Farmington Hills, Michigan, 48334, United States
-
Sage Investigational Site
Buffalo, New York, 14221, United States
-
Sage Investigational Site
New York, New York, 10032, United States
-
Sage Investigational Site
Chapel Hill, North Carolina, 27599, United States
-
Sage Investigational Site
Durham, North Carolina, 27705, United States
-
Sage Investigational Site
Cincinnati, Ohio, 45219, United States
-
Sage Investigational Site
Toledo, Ohio, 43614, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19107, United States
-
Sage Investigational Site
Charleston, South Carolina, 29425, United States
-
Sage Investigational Site
Memphis, Tennessee, 38157, United States
-
Sage Investigational Site
Nashville, Tennessee, 37212, United States
-
Sage Investigational Site
Houston, Texas, 77030, United States
-
Sage Investigational Site
Richmond, Virginia, 23298, United States
-
Sage Investigational Site
Kirkland, Washington, 98034, United States
-
Sage Investigational Site
Spokane, Washington, 99202, United States
-
Sage Investigational Site
Madison, Wisconsin, 53792, United States
-
Sage Investigational Site
Westmead, New South Wales, 2145, Australia
-
Sage Investigational Site
Herston, Queensland, 4029, Australia
-
Sage Investigational Site
Bethlehem, Victoria, 3162, Australia
-
Sage Investigational Site
Nedlands, Western Australia, 6009, Australia
-
Sage Investigational Site
Halifax, Nova Scotia, B3S 1N2, Canada
-
Sage Investigational Site
North York, Ontario, M2K 1E1, Canada
-
Sage Investigational Site
Montreal, Quebec, H2X 0A9, Canada
-
Sage Investigational Site
Tooting, London, SW17 0QT, United Kingdom
-
Sage Investigational Site
Aberdeen, AB25 2ZA, United Kingdom
-
Sage Investigational Site
Birmingham, B15 2FG, United Kingdom
-
Sage Investigational Site
Cardiff, CF10 3AX, United Kingdom
-
Sage Investigational Site
Leeds, LS7 4SA, United Kingdom
-
Sage Investigational Site
Newcastle upon Tyne, NE6 4QD, United Kingdom
-
Sage Investigational Site
Plymouth, PL6 8BT, United Kingdom
-
Sage Investigational Site
Southampton, SO16 6YD, United Kingdom